AU3876789A - Use of modified tpa to detect blood clots - Google Patents

Use of modified tpa to detect blood clots

Info

Publication number
AU3876789A
AU3876789A AU38767/89A AU3876789A AU3876789A AU 3876789 A AU3876789 A AU 3876789A AU 38767/89 A AU38767/89 A AU 38767/89A AU 3876789 A AU3876789 A AU 3876789A AU 3876789 A AU3876789 A AU 3876789A
Authority
AU
Australia
Prior art keywords
blood clots
detect blood
modified tpa
tpa
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38767/89A
Inventor
Burton E. Sobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU3876789A publication Critical patent/AU3876789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU38767/89A 1988-06-20 1989-06-16 Use of modified tpa to detect blood clots Abandoned AU3876789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20887788A 1988-06-20 1988-06-20
US208877 1994-03-11

Publications (1)

Publication Number Publication Date
AU3876789A true AU3876789A (en) 1990-01-12

Family

ID=22776392

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38767/89A Abandoned AU3876789A (en) 1988-06-20 1989-06-16 Use of modified tpa to detect blood clots

Country Status (2)

Country Link
AU (1) AU3876789A (en)
WO (1) WO1989012680A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642984B2 (en) * 1990-03-01 1993-11-04 Genentech Inc. Tissue plaminogen activator having fibrin specific properties
WO1994025581A1 (en) * 1993-05-04 1994-11-10 Southern Sydney Area Health Service Modified recombinant tissue plasminogen activator

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736122A (en) * 1991-02-08 1998-04-07 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
US5645815A (en) 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
WO1992013572A1 (en) * 1991-02-08 1992-08-20 Diatech, Inc. TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5508020A (en) 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
DK0641222T3 (en) * 1992-05-21 2000-12-11 Diatide Inc Peptides labeled with technetium-99m for thrombus imaging
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663146A (en) * 1983-07-29 1987-05-05 Codon Genetic Engineering Laboratories Methods and compositions for the diagnosis of bloodclots using plasminogen activator
DE3682891D1 (en) * 1986-02-17 1992-01-23 Stichting Centraal Lab TISSUE PLASMINOGEN ACTIVATOR MUTANT, THEREFORE ENCODING RECOMBINANT GENETIC INFORMATION AND METHOD FOR THE PRODUCTION OF THESE MUTANTS, THEIR USE AND PHARMACEUTICAL COMPOSITIONS.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642984B2 (en) * 1990-03-01 1993-11-04 Genentech Inc. Tissue plaminogen activator having fibrin specific properties
WO1994025581A1 (en) * 1993-05-04 1994-11-10 Southern Sydney Area Health Service Modified recombinant tissue plasminogen activator

Also Published As

Publication number Publication date
WO1989012680A1 (en) 1989-12-28

Similar Documents

Publication Publication Date Title
AU4285889A (en) Preparation of catheter
AU593424B2 (en) Centrifugal separation of blood
AU1811788A (en) Promotion of healing of meniscal tissue
AU537668B2 (en) Non-stirring measurement of blood coagulation time
AU590063B2 (en) Disposable diaper
AU1409488A (en) Coagulation treatment of fluids
AU4028589A (en) Femoral arterial cannula
GB8408036D0 (en) Therapeutic occlusion of blood vessels
AU6806487A (en) Tissue plasminogen activator
AU2380588A (en) Decontamination of meat
AU3375789A (en) Determination of glucose in whole blood
AU3876789A (en) Use of modified tpa to detect blood clots
AU4022289A (en) Methods of drying biological products
AU2913589A (en) Method to solubilize tissue plasminogen activator
AU7847487A (en) Cannulation of blood vessels
AU3164893A (en) Measurement of the thrombolytic activity of blood
AU4511189A (en) Specific removal of ldl from blood
AU613543B2 (en) Preparation of halofluorobenzenes
AU5413490A (en) Photochemical treatment of blood vessels
AU4703589A (en) Blood separating agent
GB8623823D0 (en) Therapeutic lysis of fibrin blood clots
AU4053489A (en) Blood glucose monitoring
AU8891691A (en) Human proteins having anticoagulant and anti-inflammatory activity
AU1892788A (en) Improvements relating to measurement of tissue plasminogen activator activity
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases